Vandana Abramson, MD
Medical Oncologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
Biological Therapy/Immunotherapy Chemotherapy Gene Therapy Pain Management Photodynamic Therapy Targeted Therapy
University of Chicago Pritzker
Medical School
Brigham and Women's Hospital
Residency
University of Pennsylvania Health System
Fellowship
American Board of Internal Medicine - Oncology
TN State Medical License: 2008 - 2017
Vanderbilt One Hundred Oaks Breast Center
Languages: English/Spanish
(615) 322-2064
719 Thompson Ln Ste 25000
Read MoreEfficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer.
Bardia, A.,Mayer, I. A.,Diamond, J. R.,Moroose, R. L.,Isakoff, S. J.,Starodub, A. N.,Shah, N. C.,O'Shaughnessy, J.,Kalinsky, K.,Guarino, M.,Abramson, V.,Juric, D.,Tola...; J. Clin. Oncol.. 2017 Mar 16.
See more >>Phase Ib study of safety and pharmacokinetics of the PI3K inhibitor SAR245408 with the HER3 neutralizing human antibody SAR256212 in patients with solid tumors.
Abramson VG, Supko JG, Ballinger T, Cleary JM, Hilton JF, Tolaney S, Chau NG, Cho DC, Lager JJ, Pearlberg J, Shapiro GI, Arteaga CL; Clin. Cancer Res.. 2016-12-28.
See more >>Towards real-time topical detection and characterization of FDG dose infiltration prior to PET imaging.
Williams JM, Arlinghaus LR, Rani SD, Shone MD, Abramson VG, Pendyala P, Chakravarthy AB, Gorge WJ, Knowland JG, Lattanze RK, Perrin SR, Scarantino CW, Townsend DW, Abr...; Eur J Nucl Med Mol Imaging. 2016 Dec.
See more >>